Location
United States, North America
Check Size
$100K - $5M
Investment Stage
Focus Areas
About Investor
Rob Hopfner serves as Managing Director and Partner at Pivotal bioVenture Partners, focusing on investments in Pharmaceuticals and BioTech sectors at seed, Series A, and Series B stages with investment ranges between $100K and $5.0M. Hopfner previously worked as Managing Director at Bay Capital and leads a $300 million life sciences venture capital fund established in 2017 that invests in privately held North American biotechnology companies from the San Francisco Bay Area.
Previous investments
Similar Investors
Abdul Ly
Seed
,Series A
,Paul Straub
Pre Seed
,Seed
,Shaun Abrahamson
Pre Seed
,Seed
,Riley Florsheim
Pre Seed
,Seed
,Steve Brownlie
Pre Seed
,Seed
,Danielle Graham
Pre Seed
,Seed
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP

Grow with the Right Investors
This profile is just one example. Our AI matches you with the investors who best fit your stage, industry, and vision.
Start Matching For Free